Results for tag: "Ceftobiprole"

Ceftobiprole is an antibiotic used to treat a variety of bacterial infections. It is a cephalosporin antibiotic, which works by inhibiting the growth of bacteria. Ceftobiprole is used to treat infections caused by Gram-positive and Gram-negative bacteria, including skin and soft tissue infections, respiratory tract infections, and urinary tract infections. It is also used to treat infections caused by certain anaerobic bacteria. Ceftobiprole is available in both oral and intravenous formulations. Ceftobiprole is a relatively new antibiotic, and is not yet widely used. It is approved for use in the United States, Canada, and Europe, and is currently being studied for use in other countries. Ceftobiprole is generally well-tolerated, with few side effects. Companies in the Ceftobiprole market include Merck & Co., Inc., Janssen Pharmaceuticals, Inc., and Basilea Pharmaceutica International Ltd. Show Less Read more